HOME >> MEDICINE >> NEWS
Spinifex secures $3.25m investment to develop pain therapy

A pain drug development company spun out of The University of Queensland has received a $3.25 million investment commitment to develop its innovative new pain therapy.

Spinifex Pharmaceuticals, an emerging biotechnology company specialising in the development of therapeutics for the treatment of neuropathic pain, has attracted investment from a syndicate including Symbiosis Group Limited, Melbourne-based GBS Venture Partners Limited and Uniseed.

Spinifex Pharmaceutical Managing Director, Dr Michael Thurn said he was delighted by the investment commitment which will help to accelerate their drug development program.

"We've several promising small molecules currently under evaluation and we plan to be in a position to start a formal toxicology program on one of those molecules in 2006," said Dr Thurn.

"The two main causes of neuropathic pain are through diabetes, affecting an estimated 45 per cent of diabetics, and through complications arising from infection with herpes zoster [shingles], known as post-herpetic neuralgia.

"We see a significant world-wide market for our pain therapy, and this investment will progress our efforts in delivering a novel solution."

Spinifex's core technology relates to the discovery (made by University of Queensland researchers led by Professor Maree Smith) of a novel pathway for the treatment of neuropathic pain. Professor Smith's group successfully validated this pathway using small molecules in well-defined animal models of neuropathic pain.

Managing Director of investment company Symbiosis, Dr Mark Harvey, said Spinifex was an attractive investment, led by a strong team with extensive experience in the international and local biotechnology industry

He said the neuropathic pain market targeted by Spinifex's technology was currently valued at US$3 billion.

"With a solid intellectual property position and several 'drug-like' molecules already in hand we expe
'"/>

Contact: Dr Michael Thurn
61-7-3842-3153
Research Australia
26-Jul-2005


Page: 1 2

Related medicine news :

1. University of Rochester spin-off secures $2 million in funding
2. Medical College of Wisconsin secures key contract from US HRSA
3. Molecular Profiling Institute secures $7.5 million in Series B funding
4. Menzies secures $1.8m in funding for the NT
5. ASU secures $3.9 million to study spinal cord injuries and neurological disorders
6. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
7. New PBS investment as PBS slows
8. Industry welcomes massive Victorian investment in medical research
9. European Science Foundation warns nanomedicine benefits will be lost without major investment
10. Medicares investment in quality improvement may not be paying off
11. Baby DVDs, videos may hinder, not help, infants language development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2019)... N.H. (PRWEB) , ... February 14, 2019 , ... ... offers multi-year operating support which will directly impact Spaulding’s programs and services. , ... impact on our organization and in the lives of the children we serve ...
(Date:2/13/2019)... ... February 13, 2019 , ... Outside of nursing, most people ... also frequent hospital units, ambulatory care centers, clinics, and even emergency departments. Their ... second edition of What to Do When Nurses Hurt Nurses, published by Sigma ...
(Date:2/13/2019)... , ... February 13, 2019 , ... With Valentine’s Day ... transmitted disease (STD) testing service, is sharing 7 tips to ensure ‘Safe Sex’: ... if you’re going to engage in safe sex. Having clear, open, and honest communication ...
(Date:2/13/2019)... GREENWICH, Conn. (PRWEB) , ... February 13, 2019 , ... ... you must clear the white stuff from walkways and driveways. Then, the snow can ... about any joint or muscle you use to remove it,” says noted orthopaedic surgeon ...
(Date:2/13/2019)... PHOENIX (PRWEB) , ... February 13, 2019 , ... ... growing eye care practice management organizations in the nation, announced a new addition ... is the first-ever stand-alone oculofacial center created within a multi-specialty ophthalmology practice. ...
Breaking Medicine News(10 mins):
(Date:2/14/2019)... ... 14, 2019 , ... Strategic Radiology announces its newest independent ... Carolina. , “We are excited to welcome the physicians and support team ... Arl Van Moore Jr, MD, Strategic Radiology CEO and Chair. “When like-minded, high-quality ...
(Date:2/13/2019)... (PRWEB) , ... February 13, 2019 , ... Researchers from ... grant from the National Institute on Aging, part of the National Institutes of Health ... in aging biology. , The program’s goals are to establish follicle-stimulating hormone (FSH), ...
(Date:2/13/2019)... ... 13, 2019 , ... Sensible Surrogacy today has launched a ... childless couples who are unable to afford the staggering cost of surrogacy in ... North America or Eastern Europe for legal and secure surrogacy procedures. However North ...
Breaking Medicine Technology:
Cached News: